Breaking News
Get 45% Off 0
🤖 Are you in? These 5 AI-picked stocks are up 15%+
Read article

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Microsoft (MSFT) Hits 52-Week High: What's Behind The Rally? By Zacks Investment Research - Jan 07, 2018

Shares of Microsoft Corporation (NASDAQ:MSFT) rallied to a 52-week high of $88.41 on Jan 5, eventually closing marginally lower at $88.19. The momentum can be attributed to its recent acquisition of...

Zacks Investment Research
Magna (MGA) Hits 52-Week High: What's Driving The Stock? By Zacks Investment Research - Jan 07, 2018

Shares of Magna International, Inc. (NYSE:MGA) scaled a 52-week high of $59.6 on Jan 5 before closing the day at $59.54 eventually.Magna has a market cap of roughly $21 billion. Average volume of...

Zacks Investment Research
GE Healthcare Partners Roche For Improved Critical Care By Zacks Investment Research - Jan 07, 2018

GE Healthcare, an operating unit of General Electric Company (NYSE:GE) , has entered into a partnership with Roche Holding (SIX:ROG) AG (OTC:RHHBY) , to create a new digital platform aimed at...

Zacks Investment Research
Galapagos Reports Topline Data From Osteoarthritis Study By Zacks Investment Research - Jan 07, 2018

Galapagos NV (NASDAQ:GLPG) announced positive top-line data from phase Ib study evaluating its osteoarthritis (“OA”) candidate, GLPG1972. The candidate reduced the level of ARGS...

Zacks Investment Research
ADTRAN (ADTN) Down More Than 21% In 3 Months: Here's Why By Zacks Investment Research - Jan 07, 2018

Shares of ADTRAN (NASDAQ:ADTN) have struggled for quite some time now due to multiple headwinds. Consequently, the stock declined 21.1% in the last three months, significantly underperforming its...

Zacks Investment Research
Pfizer To Stall R&D For Alzheimer's/Parkinson's, Cut Jobs By Zacks Investment Research - Jan 07, 2018

Pfizer, Inc. (NYSE:PFE) reportedly said in a statement that it will end R&D efforts in the Alzheimer’s and Parkinson’s disease areas, which will result in about 300 layoffs.The...

Zacks Investment Research
RTI Surgical (RTIX) To Acquire Zyga, Improve Spine Surgeries By Zacks Investment Research - Jan 07, 2018

RTI Surgical Inc. (NASDAQ:RTIX) recently executed a deal to acquire Zyga Technology Inc., a privately-held medical device company, based in Minnesota. However, successful closing of the deal is...

Zacks Investment Research
5 Reasons To Add Commerce Bancshares To Your Portfolio Now By Zacks Investment Research - Jan 07, 2018

Commerce Bancshares’ (NASDAQ:CBSH) impressive revenue growth and growing deposit and loan balances make it a promising pick right now. Moreover, a strong capital position supports its capital...

Zacks Investment Research
Why It Is Wise To Hold Huntington Bancshares Stock For Now By Zacks Investment Research - Jan 07, 2018

On Jan 5, we issued an updated research report on Huntington Bancshares (NASDAQ:HBAN) . The company’s strategic initiatives including expansion moves are likely to bolster revenue growth. Also,...

Zacks Investment Research
Energy ETFs & Stocks Soaring To Start 2018 By Zacks Investment Research - Jan 07, 2018

Oil saw a solid start to the New Year, with the return of geopolitical risk in Iran, tightening supply and soaring demand. In fact, the first trading day of 2018 marked the strongest start for oil...

Zacks Investment Research
Should Value Investors Pick Exelon Corporation (EXC) Stock? By Zacks Investment Research - Jan 07, 2018

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...

Zacks Investment Research
Deutsche Bank Might Report Third Consecutive Loss In 2017 By Zacks Investment Research - Jan 07, 2018

Deutsche Bank AG (DE:DBKGn) (NYSE:DB) will likely report annual loss consecutively for the third year, as its results are expected to be impacted by change in tax rates and poor performance of the...

Continue with Apple
Continue with Google
or
Sign up with Email